|
CA2018248A1
(en)
|
1989-06-07 |
1990-12-07 |
Clyde W. Shearman |
Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
|
|
US6800738B1
(en)
|
1991-06-14 |
2004-10-05 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
DE69534347T2
(de)
|
1994-01-31 |
2006-05-24 |
Trustees Of Boston University, Boston |
Bibliotheken aus Polyklonalen Antikörpern
|
|
ATE299938T1
(de)
|
1997-05-02 |
2005-08-15 |
Genentech Inc |
Ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
CA2410551A1
(en)
|
2000-06-30 |
2002-01-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw (Vib) |
Heterodimeric fusion proteins
|
|
DK2093286T3
(da)
|
2001-10-01 |
2013-05-13 |
Dyax Corp |
Flerkædede, eukaryote displayvektorer og anvendelser deraf
|
|
CA2501870C
(en)
|
2002-10-09 |
2013-07-02 |
Avidex Limited |
Single chain recombinant t cell receptors
|
|
LT2275441T
(lt)
|
2005-04-01 |
2016-12-12 |
Immunocore Ltd. |
Dideliu afiniškumu pasižymintys živ t ląstelių receptoriai
|
|
US9284375B2
(en)
|
2005-04-15 |
2016-03-15 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
ES2971647T3
(es)
|
2005-04-15 |
2024-06-06 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
AT503861B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von t-zell-rezeptoren
|
|
WO2008045437A2
(en)
|
2006-10-09 |
2008-04-17 |
The General Hospital Corporation |
Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
|
|
EP2152751A1
(en)
|
2007-05-31 |
2010-02-17 |
Genmab A/S |
Fusion or linked proteins with extended half life
|
|
WO2009087230A1
(en)
|
2008-01-11 |
2009-07-16 |
Morphosys Ag |
Display vectors and methods and uses thereof
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
CA2776143A1
(en)
|
2009-10-01 |
2011-04-07 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
EP2486049A1
(en)
|
2009-10-06 |
2012-08-15 |
The Board Of Trustees Of The UniversityOf Illinois |
Human single-chain t cell receptors
|
|
CA2785907A1
(en)
|
2009-12-29 |
2011-07-28 |
Emergent Product Development Seattle, Llc |
Ron binding constructs and methods of use thereof
|
|
US20130129723A1
(en)
|
2009-12-29 |
2013-05-23 |
Emergent Product Development Seattle, Llc |
Heterodimer Binding Proteins and Uses Thereof
|
|
WO2011085178A1
(en)
|
2010-01-11 |
2011-07-14 |
Trustees Of Dartmouth College |
Monomeric bi-specific fusion protein
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
PT3434767T
(pt)
|
2010-11-30 |
2026-01-23 |
Chugai Pharmaceutical Co Ltd |
Agente terapêutico indutor de citotoxicidade
|
|
EP2673300B1
(en)
|
2011-02-11 |
2016-08-24 |
Memorial Sloan-Kettering Cancer Center |
Hla-restricted, peptide-specific antigen binding proteins
|
|
WO2013026837A1
(en)
*
|
2011-08-23 |
2013-02-28 |
Roche Glycart Ag |
Bispecific t cell activating antigen binding molecules
|
|
UY34317A
(es)
|
2011-09-12 |
2013-02-28 |
Genzyme Corp |
Anticuerpo antireceptor de célula T (alfa)/ß
|
|
RU2015125639A
(ru)
|
2012-11-30 |
2017-01-10 |
Роше Гликарт Аг |
Удаление раковых клеток с помощью циркулирующих вирус-специфических цитотоксических т-клеток с использованием направленных против раковых клеток многофункциональных белков, содержащих молекулу гкгс класса i
|
|
EP2961770A1
(en)
|
2013-02-26 |
2016-01-06 |
Roche Glycart AG |
Bispecific t cell activating antigen binding molecules
|
|
LT2961771T
(lt)
*
|
2013-02-26 |
2020-03-10 |
Roche Glycart Ag |
Bispecifinės t ląstelę aktyvinančios antigeną surišančios molekulės, specifinės cd3 ir cea antigenams
|
|
SMT202100464T1
(it)
*
|
2013-03-14 |
2021-11-12 |
Macrogenics Inc |
Molecole bispecifiche che sono immunoreattive con cellule effettrici immunitarie che esprimono un recettore di attivazione
|
|
AU2014357292B2
(en)
|
2013-11-27 |
2020-06-25 |
Zymeworks Bc Inc. |
Bispecific antigen-binding constructs targeting HER2
|
|
IL263466B2
(en)
|
2013-12-17 |
2023-10-01 |
Genentech Inc |
Anti-CD3 antibodies and methods of using them
|
|
ES2927971T3
(es)
|
2014-03-25 |
2022-11-14 |
Boehringer Ingelheim Animal Health Usa Inc |
Composiciones inmunológicas que contienen Histophilus Somni atenuado
|
|
ES2878449T3
(es)
|
2014-07-24 |
2021-11-18 |
2Seventy Bio Inc |
Receptores antigénicos quiméricos de BCMA
|
|
AU2015301460B2
(en)
|
2014-08-14 |
2021-04-08 |
Novartis Ag |
Treatment of cancer using GFR alpha-4 chimeric antigen receptor
|
|
EP2985294A1
(en)
|
2014-08-14 |
2016-02-17 |
Deutsches Krebsforschungszentrum |
Recombinant antibody molecule and its use for target cell restricted T cell activation
|
|
PT3221356T
(pt)
*
|
2014-11-20 |
2020-10-29 |
Hoffmann La Roche |
Moléculas de ligação ao antigénio biespecíficas ativadoras das células t contra folr1 e cd3
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
WO2016154585A1
(en)
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
PL3298033T5
(pl)
|
2015-05-18 |
2023-10-30 |
TCR2 Therapeutics Inc. |
Kompozycje i zastosowania medyczne do reprogramowania TCR z zastosowaniem białek fuzyjnych
|
|
EP3095792A1
(en)
*
|
2015-05-19 |
2016-11-23 |
Klinikum rechts der Isar der Technischen Universität München |
T cell receptor with specificity for myeloperoxidase peptide and uses thereof
|
|
GB201510771D0
(en)
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511191D0
(en)
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201511792D0
(en)
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
|
MY189596A
(en)
|
2015-07-15 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
US10335471B2
(en)
|
2015-08-28 |
2019-07-02 |
Immatics Biotechnologies Gmbh |
Method for treating cancer with activated T cells
|
|
GB201515321D0
(en)
|
2015-08-28 |
2015-10-14 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
|
|
GB201517538D0
(en)
|
2015-10-05 |
2015-11-18 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
WO2017059900A1
(en)
|
2015-10-07 |
2017-04-13 |
Biontech Cell & Gene Therapies Gmbh |
Antigen receptors and uses thereof
|
|
HK1258444A1
(zh)
|
2015-10-09 |
2019-11-15 |
Immatics Biotechnologies Gmbh |
抗wt1/hla特异性抗体
|
|
MX2018004721A
(es)
|
2015-10-23 |
2018-07-06 |
Eureka Therapeutics Inc |
Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.
|
|
GB201521746D0
(en)
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201521894D0
(en)
|
2015-12-11 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various cancers
|
|
GB201522592D0
(en)
*
|
2015-12-22 |
2016-02-03 |
Immunocore Ltd |
T cell receptors
|
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
|
GB201602918D0
(en)
|
2016-02-19 |
2016-04-06 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
|
|
GB201603568D0
(en)
|
2016-03-01 |
2016-04-13 |
Immatics Biotechnologies Gmbh |
Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
|
|
GB201603987D0
(en)
|
2016-03-08 |
2016-04-20 |
Immatics Biotechnologies Gmbh |
Uterine cancer treatments
|
|
WO2017181001A1
(en)
|
2016-04-15 |
2017-10-19 |
Trustees Of Dartmouth College |
High affinity b7-h6 antibodies and antibody fragments
|
|
KR102436129B1
(ko)
|
2016-06-17 |
2022-08-26 |
메디진 이뮤노테라피스 게엠바하 |
T 세포 수용체 및 이의 용도
|
|
BR112018076555A2
(pt)
|
2016-06-27 |
2019-04-02 |
Procter & Gamble |
aparelho e método para avaliar o tratamento de sensibilidade dentária por produto para tratamento bucal
|
|
CA3032498A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2018026018A1
(ja)
|
2016-08-05 |
2018-02-08 |
国立大学法人東北大学 |
Ｔ細胞受容体の認識機構を用いたがん又は感染症の治療及び診断
|
|
JP2020501508A
(ja)
|
2016-09-15 |
2020-01-23 |
クアドルセプト バイオ リミテッド |
多量体、四量体および八量体
|
|
CN106831996B
(zh)
*
|
2017-03-31 |
2020-05-19 |
北京智仁美博生物科技有限公司 |
具有cd3e和/或her2靶向功能的双特异性抗体及其用途
|
|
WO2018220216A1
(en)
|
2017-06-01 |
2018-12-06 |
Universität Stuttgart |
Heterodimerizing ig domains
|
|
LT3428194T
(lt)
|
2017-07-14 |
2021-12-10 |
Immatics Biotechnologies Gmbh |
Pagerinta dvejopo savitumo polipeptido molekulė
|
|
US20200261502A1
(en)
|
2017-09-08 |
2020-08-20 |
Carsgen Therapeutics Co., Ltd. |
Genetically engineered t cell and application thereof
|
|
EP3747456A4
(en)
|
2018-01-31 |
2021-12-01 |
Tohoku University |
PROCESS FOR REGULATING THE EXPRESSION OF THE SPECIFIC MHC OF AN ANTIGEN
|
|
KR20210010896A
(ko)
|
2018-05-14 |
2021-01-28 |
이뮤노코어 리미티드 |
이기능성 결합 폴리펩타이드
|
|
EA202091977A1
(ru)
|
2018-05-28 |
2021-02-09 |
Драгонфлай Терапьютикс, Инк. |
Мультиспецифические связывающие белки, которые связывают cd33, nkg2d и cd16, и способы применения
|
|
WO2020018715A1
(en)
|
2018-07-17 |
2020-01-23 |
Massachusetts Institute Of Technology |
Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
|
|
WO2020057610A1
(en)
|
2018-09-20 |
2020-03-26 |
Wuxi Biologics (Shanghai) Co., Ltd. |
Novel bispecific anti-ctla-4/pd-1 polypeptide complexes
|
|
GB201903767D0
(en)
|
2019-03-19 |
2019-05-01 |
Quadrucept Bio Ltd |
Multimers, tetramers & octamers
|
|
GB201906685D0
(en)
|
2019-05-13 |
2019-06-26 |
Ultrahuman Six Ltd |
Activatable protein constructs and uses thereof
|
|
BR112022000790A2
(pt)
|
2019-07-15 |
2022-04-12 |
Neogene Therapeutics B V |
Método para isolar genes tcr
|
|
US20210032370A1
(en)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
EP4025598A1
(en)
|
2019-09-06 |
2022-07-13 |
Eli Lilly and Company |
Proteins comprising t-cell receptor constant domains
|
|
CN115066274A
(zh)
|
2019-09-25 |
2022-09-16 |
斯图加特大学 |
三价结合分子
|
|
JP7842011B2
(ja)
|
2019-09-27 |
2026-04-07 |
アジェナス インコーポレイテッド |
ヘテロ二量体タンパク質
|
|
KR20220098379A
(ko)
|
2019-11-15 |
2022-07-12 |
그릿스톤 바이오, 인코포레이티드 |
공유 네오항원을 표적으로 하는 항원-결합 단백질
|
|
US20220401484A1
(en)
|
2019-11-18 |
2022-12-22 |
BioNTech SE |
Prame TCR Receptors And Uses Thereof
|
|
WO2021127184A1
(en)
|
2019-12-17 |
2021-06-24 |
The Johns Hopkins University |
MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING
|
|
CN110964122B
(zh)
|
2019-12-24 |
2022-04-15 |
南京北恒生物科技有限公司 |
T细胞受体融合蛋白及其用途
|
|
US20230130925A1
(en)
|
2020-03-16 |
2023-04-27 |
University Of Southern California |
Methods to prevent, ameliorate and treat complications from viral infections
|
|
CA3171906A1
(en)
|
2020-03-16 |
2021-09-23 |
University Of Southern California |
Novel antigen binding domains and synthetic antigen receptors incorporating the same
|
|
WO2021222576A1
(en)
|
2020-05-01 |
2021-11-04 |
A2 Biotherapeutics, Inc. |
Pag1 fusion proteins and methods of making and using same
|
|
JP2023528992A
(ja)
|
2020-06-10 |
2023-07-06 |
ザ ユニバーシティー オブ メルボルン |
Ｈｉｖ－１抗体
|
|
WO2022026358A1
(en)
|
2020-07-27 |
2022-02-03 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Multifunctional immunoglobulin-fold polypeptides from alternative translational initiation and termination
|
|
US20230374140A1
(en)
|
2020-10-09 |
2023-11-23 |
Memorial Sloan Kettering Cancer Center |
Compositions targeting ndc80/mhc complexes and uses thereof
|
|
WO2022083668A1
(en)
|
2020-10-21 |
2022-04-28 |
Nanjing Legend Biotech Co., Ltd. |
Use of a chimeric co-stimulatory receptor for cell therapy
|
|
WO2022133592A1
(en)
|
2020-12-21 |
2022-06-30 |
Zymeworks Inc. |
Stabilized tcr constructs and methods of use
|
|
KR20230153529A
(ko)
|
2021-02-19 |
2023-11-06 |
프리트 엠. 쇼드하리 |
다양한 면역세포를 위한 단일사슬 및 다중사슬 합성 항원 수용체
|